CytoSMART, founded in 2012 under the name CytoMATE, is a spin-off from the TU/e.The company develops smart devices for laboratories worldwide.

Live-cell imaging has become a desired analytical tool in many cell biology laboratories that operate in the field of neurobiology, developmental biology, pharmacology. Until now live-cell imaging has been difficult, because it required large costly high-end devices that are difficult to operate.

The CytoSMART Lux2 provides a small, easy and affordable solution for live-cell imaging. The CytoSMART Lux2 is a compact inverted microscope for bright-field live cell imaging that makes live-cell imaging easy and affordable so it can be used by every biological laboratory. Even in routine cell culture processes.

“In order to continue innovation, we will further expand our organization and focus on product development. The involvement of Holland Capital enables us to do this. They understand what innovative healthcare companies need to make ambitions a reality.”

Joffry Malta

CEO, CytoSmart




Smart devices into laboratories worldwide. 


Investment period:



Transaction type:

Growth Capital